Literature DB >> 19517258

Evaluation of pulsed high intensity focused ultrasound exposures on metastasis in a murine model.

Hilary Hancock1, Matthew R Dreher, Nigel Crawford, Claire B Pollock, Jennifer Shih, Bradford J Wood, Kent Hunter, Victor Frenkel.   

Abstract

High intensity focused ultrasound (HIFU) may be employed in two ways: continuous exposures for thermal ablation of tissue (> 60 degrees C), and pulsed-exposures for non-ablative effects, including low temperature hyperthermia (37-45 degrees C), and non thermal effects (e.g. acoustic cavitation and radiation forces). Pulsed-HIFU effects may enhance the tissue's permeability for improved delivery of drugs and genes, for example, by opening up gaps between cells in the vasculature and parenchyma. Inducing these effects may improve local targeting of therapeutic agents, however; concerns exist that pulsed exposures could theoretically also facilitate dissemination of tumor cells and exacerbate metastases. In the present study, the influence of pulsed-HIFU exposures on increasing metastatic burden was evaluated in a murine model with metastatic breast cancer. A preliminary study was carried out to validate the model and determine optimal timing for treatment and growth of lung metastases. Next, the effect of pulsed-HIFU on the metastatic burden was evaluated using quantitative image processing of whole-lung histological sections. Compared to untreated controls (2/15), a greater number of mice treated with pulsed-HIFU were found to have lungs "overgrown" with metastases (7/15), where individual metastases grew together such that they could not accurately be counted. Furthermore, area fraction of lung metastases (area of metastases/area of lungs) was approximately 30% greater in mice treated with pulsed-HIFU; however, these differences were not statistically significant. The present study details the development of an animal model for investigating the influence of interventional techniques or exposures (such as pulsed HIFU) on metastatic burden.

Entities:  

Mesh:

Year:  2009        PMID: 19517258      PMCID: PMC4136696          DOI: 10.1007/s10585-009-9272-9

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  37 in total

1.  Radiation-force technique to monitor lesions during ultrasonic therapy.

Authors:  Frederic L Lizzi; Robert Muratore; Cheri X Deng; Jeffrey A Ketterling; S Kaisar Alam; Samuel Mikaelian; Andrew Kalisz
Journal:  Ultrasound Med Biol       Date:  2003-11       Impact factor: 2.998

2.  High-intensity focused ultrasound for the treatment of liver tumours.

Authors:  J E Kennedy; F Wu; G R ter Haar; F V Gleeson; R R Phillips; M R Middleton; D Cranston
Journal:  Ultrasonics       Date:  2004-04       Impact factor: 2.890

3.  The effects of shear stress and metastatic phenotype on the detachment of transformed cells.

Authors:  J L Cezeaux; V Austin; M C Hosseinipour; K A Ward; S Zimmer
Journal:  Biorheology       Date:  1991       Impact factor: 1.875

4.  Role of extracellular matrix assembly in interstitial transport in solid tumors.

Authors:  P A Netti; D A Berk; M A Swartz; A J Grodzinsky; R K Jain
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

5.  Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo.

Authors:  Douglas L Miller; Jianming Song
Journal:  Ultrasound Med Biol       Date:  2003-06       Impact factor: 2.998

6.  Investigations into pulsed high-intensity focused ultrasound-enhanced delivery: preliminary evidence for a novel mechanism.

Authors:  Hilary A Hancock; Lauren H Smith; Julian Cuesta; Amir K Durrani; Mary Angstadt; Mark L Palmeri; Eitan Kimmel; Victor Frenkel
Journal:  Ultrasound Med Biol       Date:  2009-07-17       Impact factor: 2.998

7.  Preliminary experience using high intensity focused ultrasound for the treatment of patients with advanced stage renal malignancy.

Authors:  Feng Wu; Zhi-Biao Wang; Wen-Zhi Chen; Jin Bai; Hui Zhu; Tian-Yu Qiao
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

8.  Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells.

Authors:  Gero Kramer; Georg E Steiner; Marion Gröbl; Kristian Hrachowitz; Franz Reithmayr; Ljubomir Paucz; Martin Newman; Stephan Madersbacher; Diego Gruber; Martin Susani; Michael Marberger
Journal:  Prostate       Date:  2004-02-01       Impact factor: 4.104

9.  Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice.

Authors:  Xu Fang Pei; Marcia S Noble; Maria Antonietta Davoli; Edward Rosfjord; Maddalena T Tilli; Priscilla A Furth; Robert Russell; Michael D Johnson; Robert B Dickson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Jan-Feb       Impact factor: 2.416

10.  Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound.

Authors:  Feng Wu; Zhi-Biao Wang; Cheng-Bing Jin; Jun-Ping Zhang; Wen-Zhi Chen; Jin Bai; Jian-Zhong Zou; Hui Zhu
Journal:  Ultrasound Med Biol       Date:  2004-04       Impact factor: 2.998

View more
  8 in total

Review 1.  Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.

Authors:  Natalya Rapoport
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-06-22

Review 2.  Phase-shift, stimuli-responsive drug carriers for targeted delivery.

Authors:  Brian E O'Neill; Natalya Rapoport
Journal:  Ther Deliv       Date:  2011-09

Review 3.  Focused Ultrasound for Immunomodulation of the Tumor Microenvironment.

Authors:  Jordan B Joiner; Yuliya Pylayeva-Gupta; Paul A Dayton
Journal:  J Immunol       Date:  2020-11-01       Impact factor: 5.422

4.  Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography.

Authors:  Laura E Via; Dan Schimel; Danielle M Weiner; Veronique Dartois; Emmanuel Dayao; Ying Cai; Young-Soon Yoon; Matthew R Dreher; Robin J Kastenmayer; Charles M Laymon; J Eoin Carny; Joanne L Flynn; Peter Herscovitch; Clifton E Barry
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

5.  Pulsed focused ultrasound lowers interstitial fluid pressure and increases nanoparticle delivery and penetration in head and neck squamous cell carcinoma xenograft tumors.

Authors:  Ali Mohammadabadi; Ruby N Huynh; Aniket S Wadajkar; Rena G Lapidus; Anthony J Kim; Christopher B Raub; Victor Frenkel
Journal:  Phys Med Biol       Date:  2020-06-22       Impact factor: 3.609

6.  High-intensity focused ultrasound inhibits invasion and metastasis of colon cancer cells by enhancing microRNA-124-mediated suppression of STAT3.

Authors:  Meiying Li; Guangsheng Wan; Hongjie Yu; Wei Xiong
Journal:  FEBS Open Bio       Date:  2019-05-04       Impact factor: 2.693

7.  Potentiation of scutellarin on human tongue carcinoma xenograft by low-intensity ultrasound.

Authors:  Haixia Li; Haixia Fan; Zhu Wang; Jinhua Zheng; Wenwu Cao
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

8.  A new sensitizer DVDMS combined with multiple focused ultrasound treatments: an effective antitumor strategy.

Authors:  Wenli Xiong; Pan Wang; Jianmin Hu; Yali Jia; Lijie Wu; Xiyang Chen; Quanhong Liu; Xiaobing Wang
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.